Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality.

Filipowicz R, Greene T, Wei G, Cheung AK, Raphael KL, Baird BC, Beddhu S.

Clin J Am Soc Nephrol. 2013 Jan;8(1):26-32. doi: 10.2215/CJN.12031111. Epub 2012 Nov 2.

2.

Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease.

Damera S, Raphael KL, Baird BC, Cheung AK, Greene T, Beddhu S.

Kidney Int. 2011 Jan;79(2):228-33. doi: 10.1038/ki.2010.356. Epub 2010 Sep 29.

3.

Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease.

Beddhu S, Ma X, Baird B, Cheung AK, Greene T.

Clin J Am Soc Nephrol. 2009 Nov;4(11):1805-10. doi: 10.2215/CJN.01560309. Epub 2009 Sep 3.

4.

Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.

Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV Jr, Navaneethan SD.

Am J Kidney Dis. 2013 Oct;62(4):703-10. doi: 10.1053/j.ajkd.2013.04.012. Epub 2013 Jun 12.

5.

Associations of serum alkaline phosphatase with metabolic syndrome and mortality.

Krishnamurthy VR, Baird BC, Wei G, Greene T, Raphael K, Beddhu S.

Am J Med. 2011 Jun;124(6):566.e1-7. doi: 10.1016/j.amjmed.2010.11.030.

6.

C reactive protein and long-term risk for chronic kidney disease: a historical prospective study.

Kugler E, Cohen E, Goldberg E, Nardi Y, Levi A, Krause I, Garty M, Krause I.

J Nephrol. 2015 Jun;28(3):321-7. doi: 10.1007/s40620-014-0116-6. Epub 2014 Jul 1.

PMID:
24981713
7.

Alkaline phosphatase and mortality in patients on peritoneal dialysis.

Liu X, Guo Q, Feng X, Wang J, Wu J, Mao H, Huang F, Yu X, Yang X.

Clin J Am Soc Nephrol. 2014 Apr;9(4):771-8. doi: 10.2215/CJN.08280813. Epub 2014 Jan 23.

8.

Metabolic syndrome and C-reactive protein concentration as independent correlates of chronic kidney disease.

Yang T, Chou YC, Chu CH, Lin SH, Hsieh PC, Hsu CH, Bai CH, You SL, Sun CA.

Endocr Res. 2014;39(3):94-8. doi: 10.3109/07435800.2013.840652. Epub 2013 Oct 23.

PMID:
24152229
9.

Association of serum alkaline phosphatase with mortality in non-selected European patients with CKD5D: an observational, three-centre survival analysis.

Beige J, Wendt R, Girndt M, Queck KH, Fiedler R, Jehle P.

BMJ Open. 2014 Feb 27;4(2):e004275. doi: 10.1136/bmjopen-2013-004275.

10.

Serum Albumin and High-Sensitivity C-reactive Protein are Independent Risk Factors of Chronic Kidney Disease in Middle-Aged Japanese Individuals: the Circulatory Risk in Communities Study.

Kubo S, Kitamura A, Imano H, Cui R, Yamagishi K, Umesawa M, Muraki I, Kiyama M, Okada T, Iso H; Circulatory Risk in Communities Study Investigators.

J Atheroscler Thromb. 2016 Sep 1;23(9):1089-98. doi: 10.5551/jat.33530. Epub 2016 Feb 25.

11.

Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.

Navaneethan SD, Beddhu S.

Nephrol Dial Transplant. 2009 Apr;24(4):1260-6. doi: 10.1093/ndt/gfn621. Epub 2008 Nov 25.

12.

Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005-2006.

Webber M, Krishnan A, Thomas NG, Cheung BM.

Clin Chem Lab Med. 2010 Feb;48(2):167-73. doi: 10.1515/CCLM.2010.052.

PMID:
19958209
13.

Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.

Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ Jr, Sarnak MJ, Nally JV Jr.

Nephrol Dial Transplant. 2012 Aug;27(8):3228-34. doi: 10.1093/ndt/gfs058. Epub 2012 May 2.

14.

Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients.

Chang JF, Feng YF, Peng YS, Hsu SP, Pai MF, Chen HY, Wu HY, Yang JY.

Medicine (Baltimore). 2014 Oct;93(18):e106. doi: 10.1097/MD.0000000000000106.

15.

Retinopathy and CKD as predictors of all-cause and cardiovascular mortality: National Health and Nutrition Examination Survey (NHANES) 1988-1994.

Ricardo AC, Grunwald JE, Parvathaneni S, Goodin S, Ching A, Lash JP.

Am J Kidney Dis. 2014 Aug;64(2):198-203. doi: 10.1053/j.ajkd.2014.01.437. Epub 2014 Mar 19.

16.

Light-intensity physical activities and mortality in the United States general population and CKD subpopulation.

Beddhu S, Wei G, Marcus RL, Chonchol M, Greene T.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1145-53. doi: 10.2215/CJN.08410814. Epub 2015 Apr 30.

17.

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.

Missailidis C, Hällqvist J, Qureshi AR, Barany P, Heimbürger O, Lindholm B, Stenvinkel P, Bergman P.

PLoS One. 2016 Jan 11;11(1):e0141738. doi: 10.1371/journal.pone.0141738. eCollection 2016.

18.

C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease.

Jalal D, Chonchol M, Etgen T, Sander D.

J Nephrol. 2012 Sep-Oct;25(5):719-25. doi: 10.5301/jn.5000047.

19.

Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.

Kovesdy CP, Ureche V, Lu JL, Kalantar-Zadeh K.

Nephrol Dial Transplant. 2010 Sep;25(9):3003-11. doi: 10.1093/ndt/gfq144. Epub 2010 Mar 17.

20.

The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.

Fox ER, Benjamin EJ, Sarpong DF, Nagarajarao H, Taylor JK, Steffes MW, Salahudeen AK, Flessner MF, Akylbekova EL, Fox CS, Garrison RJ, Taylor HA Jr.

BMC Nephrol. 2010 Jan 15;11:1. doi: 10.1186/1471-2369-11-1.

Supplemental Content

Support Center